--- title: "Precision Medicine " description: "Learn what precision medicine means, including its definition, precision health care benefits, personalized genetic testing, and how precision medical care…" url: https://www.independentpress.com/article/precision-medicine date: 2025-12-10 categories: ["Technology","Healthcare"] author: "By Tomer Shapira " --- # Precision Medicine ![DNA](https://images.ctfassets.net/ewtdlsoyixc1/1xKVqZElO22OmObUIQJzlN/7a261d30d0a89bab2c5a4d59f7a1248e/precision_medicine1.jpeg) **Introduction ** With the growth of molecular profiling, DNA sequencing, and Artificial Intelligence, precision medicine has started to become a popular approach in healthcare for addressing and preventing diseases. The practice of precision medicine customizes medical treatments to individual patients by accounting for factors such as variability in genes, environment, and lifestyle. The use of multi-modal datasets combined with AI models prescribes therapies that are personalized for each patient based on their individual composition. The practice has started to replace older medical customs that were made for larger populations and tailored to the ‘average patient’. Ultimately, the hope is that precision medicine can help medical professionals shift from a reactive approach to a proactive one so that personalized interventions can be implemented to predict and prevent health issues. **How Precision Medicine Began** Precision Medicine came to prominence after World War II as governments invested heavily in biostatistics and medical computing to better measure patient data. The government investment allowed for larger clinical trials and broader disease classifications laying the foundation for a more nuanced approach in assessing patient health and prescribing treatments. A second major catalyst occurred in 1990 with the launch of the Human Genome Project. Scientists from across the world combined their resources to chart every gene present in human DNA. The project produced a clear map showing where all the genes are located and how our human DNA is arranged. The Human Genome Project helped provide scientists and doctors with a better understanding of disease epidemiology that has allowed for cheaper and more personalized medicine. The project was completed in 2003, and the resulting data on DNA and the human genome was made available to the public. Another major catalyst happened in 2015 when the U.S. Precision Medicine Initiative was launched by the National Institute of Health (NIH) and multiple research agencies. The goal of the initiative is to encourage a new form of healthcare where treatment is patient-specific and focused on individual biology. Precision medicine has also been aided through the development of medical devices that collect data and multiomics which allows for large datasets containing different types of biological data to be analyzed and compared to provide a holistic view of patient health. **Investing in AI-based solutions ** As precision medicine continues to grow, companies and research groups are turning to Artificial Intelligence to help pull valuable information from complex datasets that were once too large for us to comprehend. These AI systems examine millions of data points and formulate conclusions from these vast datasets. AI can spot complex patterns and predict what type of disease a patient might develop or how they might respond to a particular drug. The future potential for precision medicine is extremely promising and as a result investors have started investing large amounts of money into AI tools supporting diagnosis, drug discovery, imaging analysis, and risk prediction. These tools make precision medicine faster, more accurate, and more valuable across the healthcare world. **AI in Precision Medicine Market Size (USD Billion) ** ![AI in Precision Medicine Market Size (USD Billion) ](https://images.ctfassets.net/ewtdlsoyixc1/2M3J4BDDDuciFUnkWP33jV/74cca47f8e84d41cb75ef34892378029/asset1.png) **** **Future Potential ** The healthcare system is increasingly moving towards precision medicine and treatments that are personalized, fast, and based on real data. One sector that should benefit from this transformation in medicine is the Artificial Intelligence industry. As more genetic tests and real-time health data are collected by hospitals, the need for AI tools to make sense of this data will only continue to grow. AI companies serving the healthcare and biotech industries will profit from strong long-term demand curves and huge barriers to entry that protect existing companies against rapid competition. AI tools offer several advantages including providing reduced cost of drug discovery, improved accuracy in diagnosis, and better outcomes for patients. The healthcare industry is currently moving toward deeper integrations of AI in nearly every step of patient care. This includes AI-powered digital twins that model how a treatment might affect a patient, AI systems that design new drugs, and tools able to predict health problems years before symptoms appear. A likely future for precision medicine is a world were vast data collected from wearable medical devices is synchronized with AI tools to prescribe treatments for each of us individually, thereby lowering healthcare costs and increasing life expectancy rates. **AI in Precision Medicine Market Share ** ![AI in Precision Medicine Market Share ](https://images.ctfassets.net/ewtdlsoyixc1/26alwlntMqz39APoPvGgYn/ea4aa5a058989aadc0d24817c74f839c/asset2.png) **** **The Main Players in Precision Medicine ** There are several companies in the healthcare industry that specialize in integrating AI solutions with precision medicine. The main players in the market are Tempus, Illumina, and Recursion Pharmaceuticals. [Tempus](http://www.tempus.com/) uses AI to study huge sets of genetic and clinical data, which helps doctors choose the best treatment for cancer patients. This is done by comparing datasets to thousands of similar cases and using those comparisons to draw conclusions. [Illumina](http://www.illumina.com/) makes the DNA sequencing machines that produce most of the genetic data used in research and patient care. As sequencing gets cheaper and more common, Illumina will be a core player in helping to profile the genetic makeup of individual patients. [Recursion](http://www.recursion.com/)[Pharmaceuticals](http://www.recursion.com/) focuses on AI-driven drug discovery by running automated tests and digital models capable of exploring millions of options in a very short period of time. Each of these companies sit at the center of the shift toward data-driven healthcare, and each one has strong growth potential as AI becomes deeply integrated in healthcare and how we treat and prevent disease. **Conclusion ** Overall, precision medicine has grown from early data collection after World War II into an AI-driven approach that reshapes how we conceptualize and treat disease. The Human Genome Project, the rise of multiomics, and the U.S. Precision Medicine Initiative have all helped the field accelerate its grow. Today, AI sits at the center of the movement enabling doctors to predict risks and tailor treatments that are specific to individual patients. As datasets continue to expand in size and complexity and AI becomes increasingly sophisticated, precision medicine will only continue to evolve in scope. Together AI, wearable medical devices, and genetic/molecular sequencing will help to usher in an age of precision medicine based on proactive healthcare and personalized treatment.